Paper Details

  1. Home
  2. Paper Details

Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.

Author: BraidoF, LatorreM, NovelliF, PaggiaroP, PapiA, SanduzziA, SantusP, ScichiloneN, VagagginiB

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Budesonide/formoterol and fluticasone/salmeterol, commonly used ICS/LABA combinations for COPD, show similar efficacy but differ in their pharmacokinetic characteristics and risk of pneumonia.
Paper Details　
Original Abstract of the Article :
Inhaled corticosteroids (ICS) are frequently recommended for the treatment of asthma and COPD, often in combination with long-acting beta2-agonists (LABA), depending on the severity of the disease and/or on the specific phenotype. Several ICS/LABA combinations are currently available that differ in ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.pupt.2014.10.006

データ提供：米国国立医学図書館（NLM）

Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD)

Chronic obstructive pulmonary disease (COPD) is a debilitating lung condition that affects millions worldwide. Inhaled corticosteroids (ICS) and long-acting beta2-agonists (LABA) are commonly prescribed in combination to manage COPD symptoms. However, not all ICS/LABA combinations are created equal, and this study dives into the differences in efficacy and safety profiles of two popular combinations: budesonide/formoterol and fluticasone/salmeterol. The researchers discovered that [主要な発見] This research is crucial for making informed decisions about treatment options for COPD patients.

Navigating COPD Treatment: A Careful Choice

The findings of this study reveal that [社会的な意義] for COPD patients. While both combinations show similar efficacy in reducing exacerbations and improving lung function, the increased risk of pneumonia associated with fluticasone requires careful consideration.

COPD and Inhaled Medications: A Balancing Act

COPD treatment involves a delicate balance between managing symptoms and minimizing potential side effects. This study suggests that [健康的なベネフィットもしくはリスク] for COPD patients. It's essential to discuss these differences with your doctor and make an informed decision about the best course of treatment for your specific needs.

Dr.Camel's Conclusion

Imagine COPD as a desert storm, constantly swirling and affecting lung function. This study offers a valuable guide for navigating the therapeutic landscape of COPD treatment. It's like choosing the right camel for your journey through the desert: some camels are better equipped for certain terrains, and so are certain ICS/LABA combinations for different COPD patients. The key is to choose the right combination based on your individual needs and consult with your doctor.

Date :
  1. Date Completed 2015-11-03
  2. Date Revised 2015-02-14
Further Info :

Pubmed ID

25445928

DOI: Digital Object Identifier

10.1016/j.pupt.2014.10.006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.